Literature DB >> 10520936

The molecular pathogenesis of Pelizaeus-Merzbacher disease.

J Garbern1, F Cambi, M Shy, J Kamholz.   

Abstract

In 1885, Pelizaeus described 5 boys in a single family with nystagmus, spastic quadriparesis, ataxia, and delay in cognitive development. In 1910, Merzbacher reexamined this family, which then included 14 affected individuals, including 2 girls, and found that all affected family members shared a common female ancestor. Also, he noted that the disease was passed exclusively through the female line without male-to-male transmission. Pathological analysis of brain tissue from one affected individual showed that most of the central white matter lacked histochemical staining for myelin, although there were occasional small regions of preserved myelin, giving the sections a "tigroid" appearance. The description of this family provides the clinical, genetic, and pathological basis for Pelizaeus-Merzbacher disease (PMD): an X-linked disorder of myelination classically characterized by nystagmus, spastic quadriparesis, ataxia, and cognitive delay in early childhood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10520936     DOI: 10.1001/archneur.56.10.1210

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

1.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.

Authors:  Ken Inoue; Hitoshi Osaka; Virginia C Thurston; Joe T R Clarke; Akira Yoneyama; Lisa Rosenbarker; Thomas D Bird; M E Hodes; Lisa G Shaffer; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

Review 2.  Gap junctions couple astrocytes and oligodendrocytes.

Authors:  Jennifer L Orthmann-Murphy; Charles K Abrams; Steven S Scherer
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

3.  Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.

Authors:  Sunita Appikatla; Denise Bessert; Icksoo Lee; Maik Hüttemann; Chadwick Mullins; Mallika Somayajulu-Nitu; Fayi Yao; Robert P Skoff
Journal:  Glia       Date:  2013-12-31       Impact factor: 7.452

4.  Connatal Pelizaeus-Merzbacher disease: a great masquerader.

Authors:  Sushil Beri; Nahin Hussain; Jayaprakash A Gosalakkal
Journal:  Indian J Pediatr       Date:  2010-03       Impact factor: 1.967

Review 5.  Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease.

Authors:  M Joana Osorio; David H Rowitch; Paul Tesar; Marius Wernig; Martha S Windrem; Steven A Goldman
Journal:  Stem Cells       Date:  2016-11-23       Impact factor: 6.277

6.  Insertion of mutant proteolipid protein results in missorting of myelin proteins.

Authors:  Catherine Vaurs-Barriere; Kondi Wong; Thais D Weibel; Mones Abu-Asab; Michael D Weiss; Christine R Kaneski; Tong-Hui Mixon; Simona Bonavita; Isabelle Creveaux; John D Heiss; Maria Tsokos; Ehud Goldin; Richard H Quarles; Odile Boespflug-Tanguy; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

7.  Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.

Authors:  Jennifer L Orthmann-Murphy; Ettore Salsano; Charles K Abrams; Alberto Bizzi; Graziella Uziel; Mona M Freidin; Eleonora Lamantea; Massimo Zeviani; Steven S Scherer; Davide Pareyson
Journal:  Brain       Date:  2008-12-04       Impact factor: 13.501

8.  The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease.

Authors:  Cherie M Southwood; James Garbern; Wei Jiang; Alexander Gow
Journal:  Neuron       Date:  2002-11-14       Impact factor: 17.173

9.  Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.

Authors:  Daniella Magen; Costa Georgopoulos; Peter Bross; Debbie Ang; Yardena Segev; Dorit Goldsher; Alexandra Nemirovski; Eli Shahar; Sarit Ravid; Anthony Luder; Bayan Heno; Ruth Gershoni-Baruch; Karl Skorecki; Hanna Mandel
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

10.  Genomic and Proteomic Biomarker Discovery in Neurological Disease.

Authors:  Rilee H Robeson; Andrew M Siegel; Travis Dunckley
Journal:  Biomark Insights       Date:  2008-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.